Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2021-01-21 2020-10-01
Drug Identification Number 02299224 02299224
Brand name TEVA-FLUVASTATIN TEVA-FLUVASTATIN
Common or Proper name FLUVASTATIN 20MG CAPS FLUVASTATIN 20MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients FLUVASTATIN FLUVASTATIN
Strength(s) 20MG 20MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-30 2020-09-30
Estimated end date 2021-03-31 2020-11-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments